Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: Breast Cancer Res Treat. 2019 Feb 6;175(1):247–259. doi: 10.1007/s10549-019-05156-5

Figure 5. Tumor Immune Dysfunction and Exclusion (TIDE) scores by patient race and tumor subtype.

Figure 5.

The mean TIDE, IFN-gamma (“IFNG”), T-cell dysfunction (“Dysfunction”), and T-cell exclusion (“Exclusion”) scores are displayed for each race cohort with error bars representing standard error of the mean. The means of AA scores are in dark grey; the means of Caucasian scores are in light grey. A) Signatures for TNBC cases only, B) Signatures for ER-positive cases only.